Dewpoint Therapeutics

Dewpoint Therapeutics is a biotechnology company focused on developing treatments for diseases by targeting biomolecular condensates, which are cellular structures that organize and regulate biochemical processes. They leverage their proprietary platform to identify and manipulate these condensates to discover novel therapeutic approaches. Founded in 2018, Dewpoint has rapidly advanced its research and development efforts, forming strategic partnerships with major pharmaceutical companies to accelerate the commercialization of its discoveries. The company generates revenue through collaborations, licensing agreements, and potential future sales of its therapeutic products.

Recent Posts by Dewpoint Therapeutics

1-2 of 2